Cortisol response during different anxiogenic challenges in panic disorder patients
- PMID: 1484913
- DOI: 10.1016/0306-4530(92)90003-p
Cortisol response during different anxiogenic challenges in panic disorder patients
Abstract
The present study assessed the relation of cortisol response to anxiogenic reactivity during intravenous lactate infusion and oral fenfluramine in 12 panic disorder (PD) patients who responded positively to both challenges and in eight non-reactive control subjects. There was no significant cortisol response difference between the PD patients and the controls during lactate infusion, but there was s significant difference at 120 min during the fenfluramine challenge. These findings are consistent with the possibility that these challenges stimulate different neurobiologic mechanisms and that fenfluramine-precipitated anxiety is more akin to anticipatory or generalized anxiety than to true panic anxiety.
Similar articles
-
Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder.Biol Psychiatry. 1990 Jul 1;28(1):21-34. doi: 10.1016/0006-3223(90)90428-5. Biol Psychiatry. 1990. PMID: 2375944
-
Panic attack frequency and vulnerability to anxiogenic challenge studies.Psychiatry Res. 1991 Jan;36(1):75-83. doi: 10.1016/0165-1781(91)90119-a. Psychiatry Res. 1991. PMID: 2017525
-
Fenfluramine provocation of anxiety in patients with panic disorder.Psychiatry Res. 1989 Jun;28(3):295-306. doi: 10.1016/0165-1781(89)90210-2. Psychiatry Res. 1989. PMID: 2669003 Clinical Trial.
-
[Stress, anxiety, panic. Panic attack and panic disorder. A new psychiatric concept].Encephale. 1993 Mar;19 Spec No 1:187-91. Encephale. 1993. PMID: 8281900 Review. French.
-
The lactic acid response to alkalosis in panic disorder : an integrative review.J Neuropsychiatry Clin Neurosci. 2001 Winter;13(1):22-34. doi: 10.1176/jnp.13.1.22. J Neuropsychiatry Clin Neurosci. 2001. PMID: 11207326 Review.
Cited by
-
Physiological, biochemical and subjective parameters in anxiety patients with panic disorder during stress exposure as compared with healthy controls.Eur Arch Psychiatry Clin Neurosci. 1997;247(5):264-74. doi: 10.1007/BF02900305. Eur Arch Psychiatry Clin Neurosci. 1997. PMID: 9444496 Clinical Trial.
-
Peripheral Biomarkers in DSM-5 Anxiety Disorders: An Updated Overview.Brain Sci. 2020 Aug 17;10(8):564. doi: 10.3390/brainsci10080564. Brain Sci. 2020. PMID: 32824625 Free PMC article. Review.
-
Decreased Systemic Monocyte Colony Protein-1 (MCP-1) Levels and Reduced sCD14 Levels in Curcumin-Treated Patients with Moderate Anxiety: A Pilot Study.Antioxidants (Basel). 2024 Aug 29;13(9):1052. doi: 10.3390/antiox13091052. Antioxidants (Basel). 2024. PMID: 39334711 Free PMC article.
-
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.World J Biol Psychiatry. 2017 Apr;18(3):162-214. doi: 10.1080/15622975.2016.1190867. Epub 2016 Jul 15. World J Biol Psychiatry. 2017. PMID: 27419272 Free PMC article. Review.
-
Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks.Neurosci Biobehav Rev. 2014 Oct;46 Pt 3:429-54. doi: 10.1016/j.neubiorev.2014.07.027. Epub 2014 Aug 15. Neurosci Biobehav Rev. 2014. PMID: 25130976 Free PMC article. Review.